Clinical Trial: A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease

U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07677358) titled 'A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease' on June 24.

Brief Summary: The purpose of this study to understand how the study medicine atirmociclib behaves in the body and how safe it is for people with different levels of liver health.

The study is seeking participants who are:

* Aged 18 years or older

* Have a BMI of 17.5 to 40 kg/m2, and body weight more than 50 kg.

* Have normal liver function or have stable mild, moderate, or severe liver disease

Participants will receive study medicine by mouth. Blood samples w...